NCT00389025View on ClinicalTrials.gov

Mast-Cell Stabilizing Effects of Olopatadine

PHASE4CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

April 30, 2007

Conditions

Allergic Conjunctivitis

Interventions

DRUG

Olopatadine (generic name)

Trial Locations (1)

Unknown

Padova Site, Padua

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alcon Research

INDUSTRY